Rei medica - Company finances
|
EUR
|
2018
From: 2018-06-18
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 480 | 7,768 | 17,968 | 7,070 | 6,491 | 6,915 | 7,550 | 15,401 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -159 | -3,728 | 2,252 | -3,324 | -5,412 | -4,193 | -4,248 | -4,211 |
| Equity | 104,841 | 101,113 | 103,365 | 100,042 | 94,630 | 90,437 | 86,189 | 81,978 |
| Liabilities | 509 | 1,200 | 5,220 | 2,452 | 2,888 | 3,140 | 3,575 | 2,884 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 105,350 | 102,313 | 108,585 | 102,494 | 97,518 | 93,577 | 89,764 | 84,862 |
| Total assets | 105,350 | 102,313 | 108,585 | 102,494 | 97,518 | 93,577 | 89,764 | 84,862 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,574 | 1,650 | 3,840 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +1518.3% | +131.3% | -60.7% | -8.2% | +6.5% | +9.2% | +104.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.2% | -3.6% | 2.1% | -3.2% | -5.5% | -4.5% | -4.7% | -5.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -0.2% | -3.7% | 2.2% | -3.3% | -5.7% | -4.6% | -4.9% | -5.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -33.1% | -48.0% | 12.5% | -47.0% | -83.4% | -60.6% | -56.3% | -27.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 480 | 7,768 | 17,968 | 7,070 | 6,491 | 6,915 | 7,550 | 15,401 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Rei medica - Social security debts
The company had no debts to Sodra
Rei medica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-09-06 | 2025-09-08 | 0.01 |
| 2025-07-12 | 2025-07-20 | 0.01 |
| 2025-06-10 | 2025-06-12 | 0.01 |
| 2025-04-11 | 2025-04-14 | 0.01 |
| 2025-01-09 | 2025-01-09 | 32.37 |
| 2024-12-08 | 2024-12-08 | 32.28 |
| 2024-12-07 | 2024-12-07 | 32.16 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Rei medica, UAB (code 304859891) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, revenue increased to €15.4K from €7.5K in 2024 and €6.9K in 2023, indicating a clear two-year upward trend in sales. Net profit remained negative at about €4.2K in each of the last three years, but the loss rate improved as revenue expanded, with the profit margin narrowing to -27.3% in 2025 from -56.3% in 2024 and -60.6% in 2023. Total assets decreased from €93.6K in 2023 to €84.9K in 2025, while equity declined from €90.4K to €82.0K and liabilities stayed low at €2.9K. The company is therefore financed mainly by equity, reflected in an equity ratio of 96.6% and a debt-to-equity ratio of 0.04. In 2025, return on equity was -5.1% and return on assets -5.0%. Asset turnover stood at 0.18x, and revenue per employee was €15.4K.